Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology

被引:8
|
作者
Palesh, Oxana [1 ]
Demark-Wahnefried, Wendy [2 ]
Mustian, Karen [3 ]
Minasian, Lori [4 ]
Rowland, Julia [4 ]
Sprod, Lisa [3 ]
Janelsins, Michelle [3 ]
Peppone, Luke [3 ]
Sloan, Jeff [5 ]
Engquist, Karen Basen [6 ]
Jones, Lee [7 ]
Buist, Diana [8 ]
Paskett, Electra D. [9 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Univ Rochester, Ctr Canc, Rochester, NY USA
[4] NCI, Bethesda, MD 20892 USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Univ Washington, Seattle, WA 98195 USA
[9] Ohio State Univ, Columbus, OH 43210 USA
关键词
LONG-TERM SURVIVORS; INDUCED BONE LOSS; BREAST-CANCER; CHEMOTHERAPY; WOMEN;
D O I
10.1158/1055-9965.EPI-11-0176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As the number of cancer survivors expands, the need for cancer control and survivorship research becomes increasingly important. The National Cancer Institute (NCI) Cooperative Groups may offer a viable platform to perform such research. Observational, preventive, and behavioral research can often be performed within the cooperative group setting, especially if resources needed for evaluation are fairly simple, if protocols are easily implemented within the typical clinical setting, and if interventions are well standardized. Some protocols are better suited to cooperative groups than are others, and there are advantages and disadvantages to conducting survivorship research within the cooperative group setting. Behavioral researchers currently involved in cooperative groups, as well as program staff within the NCI, can serve as sources of information for those wishing to pursue symptom management and survivorship studies within the clinical trial setting. The structure of the cooperative groups is currently changing, but going forward, survivorship is bound to be a topic of interest and one that perhaps may be more easily addressed using the proposed more centralized structure. Cancer Epidemiol Biomarkers Prev; 20(5); 1050-5. (C) 2011 AACR.
引用
收藏
页码:1050 / 1055
页数:6
相关论文
共 50 条
  • [1] Strategies to maximize the competitiveness of cancer survivorship grant applications: A report from the American Society of Preventive Oncology's Survivorship Interest Group
    Geiger, Ann M.
    Strom, Sara S.
    Demark-Wahnefried, Wendy
    Buist, Diana S. M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2899 - 2900
  • [2] The Role of Dissemination and Implementation Research in Global Tobacco Control: A Report from the American Society of Preventive Oncology
    Salloum, Ramzi G.
    Parascandola, Mark
    LeLaurin, Jennifer H.
    Shelley, Donna
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (12) : 2740 - 2743
  • [3] Cancer Prevention after Cancer: Changing the Paradigm-a Report from the American Society of Preventive Oncology
    Campo, Rebecca A.
    Rowland, Julia H.
    Irwin, Melinda L.
    Nathan, Paul C.
    Gritz, Ellen R.
    Kinney, Anita Y.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (10) : 2317 - 2324
  • [4] Identification of Key Gaps in Cancer Survivorship Research: Findings From the American Society of Clinical Oncology Survey
    Jacobsen, Paul B.
    Rowland, Julia H.
    Paskett, Electra D.
    Van Leeuwen, Flora
    Moskowitz, Chaya
    Katta, Sweatha
    Wollins, Dana
    Robison, Leslie L.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (03) : 190 - +
  • [5] Undertaking Cancer Research in International Settings: Report from the American Society for Preventive Oncology Special Interest Group on International Issues in Cancer
    Wernli, Karen J.
    Kitahara, Cari M.
    Tamers, Sara L.
    Al-Temimi, Mohammed H.
    Braithwaite, Dejana
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1638 - 1641
  • [6] American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
    Day, S.
    Bevers, T. B.
    Palos, G. R.
    Rodriguez, M. A.
    BREAST DISEASES, 2016, 27 (04): : 327 - 329
  • [7] American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
    Runowicz, Carolyn D.
    Leach, Corinne R.
    Henry, N. Lynn
    Henry, Karen S.
    Mackey, Heather T.
    Cowens-Alvarado, Rebecca L.
    Cannady, Rachel S.
    Pratt-Chapman, Mandi L.
    Edge, Stephen B.
    Jacobs, Linda A.
    Hurria, Arti
    Marks, Lawrence B.
    LaMonte, Samuel J.
    Warner, Ellen
    Lyman, Gary H.
    Ganz, Patricia A.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (01) : 44 - 73
  • [8] American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
    Runowicz, Carolyn D.
    Leach, Corinne R.
    Henry, N. Lynn
    Henry, Karen S.
    Mackey, Heather T.
    Cowens-Alvarado, Rebecca L.
    Cannady, Rachel S.
    Pratt-Chapman, Mandi L.
    Edge, Stephen B.
    Jacobs, Linda A.
    Hurria, Arti
    Marks, Lawrence B.
    LaMonte, Samuel J.
    Warner, Ellen
    Lyman, Gary H.
    Ganz, Patricia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 611 - +
  • [9] Current research promises and challenges in behavioral oncology: Report from the American Society of Preventive Oncology Annual Meeting, 2002
    Miller, SM
    Bowen, DJ
    Campbell, MK
    Diefenbach, MA
    Gritz, ER
    Jacobsen, PB
    Stefanek, M
    Fang, CY
    Lazovich, D
    Sherman, KA
    Wang, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 171 - 180
  • [10] Job Satisfaction in Cancer Prevention and Control: A Survey of the American Society of Preventive Oncology
    O'Neill, Suzanne C.
    Thompson, Cheryl L.
    Kapp, Julie M.
    Worthington, Julie L.
    Graves, Kristi D.
    Madlensky, Lisa
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) : 2110 - 2112